- Report
- July 2023
- 80 Pages
Ireland
From €2469EUR$2,595USD£2,114GBP
- Report
- July 2023
- 80 Pages
Brazil
From €2469EUR$2,595USD£2,114GBP
- Report
- July 2023
- 80 Pages
Vietnam
From €2469EUR$2,595USD£2,114GBP
- Report
- July 2023
- 80 Pages
Poland
From €2469EUR$2,595USD£2,114GBP
- Report
- July 2023
- 100 Pages
Africa
From €3611EUR$3,795USD£3,092GBP
- Report
- December 2023
- 132 Pages
Global
From €904EUR$950USD£774GBP
- Report
- April 2021
- 117 Pages
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- August 2023
- 168 Pages
Global
From €2853EUR$2,999USD£2,443GBP
- Report
- September 2022
- 244 Pages
Global
From €3397EUR$3,570USD£2,908GBP
- Report
- March 2021
- 141 Pages
South Korea
From €1852EUR$1,946USD£1,585GBP
- Report
- September 2023
- 140 Pages
Global
From €2853EUR$2,999USD£2,443GBP
- Book
- March 2024
- 544 Pages
- Book
- May 2021
- 832 Pages
- Book
- October 2018
- 400 Pages
The 3D Cell Culture market is a subset of the biotechnology industry that focuses on the development of three-dimensional (3D) cell cultures for research and therapeutic applications. 3D cell cultures are a type of in vitro cell culture that more closely mimics the natural environment of cells in the body, allowing for more accurate and reliable results. This technology has been used to study a variety of diseases, including cancer, and to develop new treatments.
3D cell cultures are also used in drug discovery and development, as well as in the production of biologics and tissue engineering. This technology has the potential to revolutionize the biotechnology industry, as it can provide more accurate and reliable results than traditional two-dimensional (2D) cell cultures.
Some companies in the 3D Cell Culture market include Thermo Fisher Scientific, Corning, Merck KGaA, Lonza, and InSphero. Show Less Read more